Phuc-loi Luu
384 Victoria St
Sydney, NSW 2010, Australia
Sydney, NSW 2010, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Comprehensive methylome sequencing reveals prognostic epigenetic biomarkers for prostate cancer mortality.
Journal: Clinical and translational medicine
Published: March 24, 2022
Identification of DNA methylation biomarkers with potential to predict response to neoadjuvant chemotherapy in triple-negative breast cancer.
Journal: Clinical epigenetics
Published: September 24, 2021
MethPanel: a parallel pipeline and interactive analysis tool for multiplex bisulphite PCR sequencing to assess DNA methylation biomarker panels for disease detection.
Journal: Bioinformatics (Oxford, England)
Published: August 26, 2020
BRG1 knockdown inhibits proliferation through multiple cellular pathways in prostate cancer.
Journal: Clinical epigenetics
Published: August 24, 2020
Comprehensive evaluation of targeted multiplex bisulphite PCR sequencing for validation of DNA methylation biomarker panels.
Journal: Clinical epigenetics
Published: February 18, 2020
Benchmark study comparing liftover tools for genome conversion of epigenome sequencing data.
Journal: NAR genomics and bioinformatics
Published: November 25, 2019
Constitutively bound CTCF sites maintain 3D chromatin architecture and long-range epigenetically regulated domains.
Journal: Nature communications
Published: February 04, 2019
Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine-resistant breast cancer.
Journal: Nature communications
Published: December 02, 2018
Guidelines for whole genome bisulphite sequencing of intact and FFPET DNA on the Illumina HiSeq X Ten.
Journal: Epigenetics & chromatin
Published: February 09, 2018
Rules governing the mechanism of epigenetic reprogramming memory.
Journal: Epigenomics
Published: January 17, 2018
Last Updated: 09/26/2026